{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:17:33Z","timestamp":1787066253488,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["T32DC000027"],"award-info":[{"award-number":["T32DC000027"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Otorhinolaryngol Rep"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40136-017-0153-5","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T01:00:38Z","timestamp":1493773238000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Intratympanic (IT) Therapies for Meni\u00e8re\u2019s Disease: Some Consensus Among the Confusion"],"prefix":"10.1007","volume":"5","author":[{"given":"Desi P.","family":"Schoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace X.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Ehrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth E.","family":"Pross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan K.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"153_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","volume":"113","author":"Committee on Hearing and Equilibrium","year":"1995","unstructured":"Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere\u2019s disease. Otolaryngol Head Neck Surg. 1995;113:181\u20135.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/VES-150549","volume":"25","author":"JA Lopez-Escamez","year":"2015","unstructured":"Lopez-Escamez JA, Carey J, Chung W-H, et al. Diagnostic criteria for Meni\u00e8re\u2019s disease. J Vestib Res. 2015;25:1\u20137.","journal-title":"J Vestib Res"},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1097\/MAO.0000000000001227","volume":"37","author":"PR Lambert","year":"2016","unstructured":"Lambert PR, Carey J, Mikulec AA, LeBel C. Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of M\u00e9ni\u00e8re\u02bcs disease. Otol Neurotol. 2016;37:1669\u201376.","journal-title":"Otol Neurotol"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.otc.2010.05.001","volume":"43","author":"TH Alexander","year":"2010","unstructured":"Alexander TH, Harris JP. Current epidemiology of Meniere\u2019s syndrome. Otolaryngol Clin N Am. 2010;43:965\u201370.","journal-title":"Otolaryngol Clin N Am"},{"key":"153_CR5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1288\/00005537-198408000-00020","volume":"94","author":"P Wladislavosky-Waserman","year":"1984","unstructured":"Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT. Meniere\u2019s disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope. 1984;94:1098\u2013102.","journal-title":"Laryngoscope"},{"key":"153_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.otohns.2005.06.015","volume":"133","author":"M Havia","year":"2005","unstructured":"Havia M, Kentala E, Pyykk\u00f6 I. Prevalence of Meniere\u2019s disease in general population of Southern Finland. Otolaryngol Head Neck Surg. 2005;133:762\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/00129492-200111000-00030","volume":"22","author":"JP Anderson","year":"2001","unstructured":"Anderson JP, Harris JP. Impact of Meniere\u2019s disease on quality of life. Otol Neurotol. 2001;22:888\u201394.","journal-title":"Otol Neurotol"},{"key":"153_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/00129492-200107000-00020","volume":"22","author":"AC S\u00f6derman","year":"2001","unstructured":"S\u00f6derman AC, Bergenius J, Bagger-Sj\u00f6b\u00e4ck D, et al. Patients\u2019 subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol. 2001;22:526\u201333.","journal-title":"Otol Neurotol"},{"key":"153_CR9","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1097\/MLG.0b013e3180caa14f","volume":"117","author":"JD Green","year":"2007","unstructured":"Green JD, Verrall A, Gates GA. Quality of life instruments in Meniere\u2019s disease. Laryngoscope. 2007;117:1622\u20138.","journal-title":"Laryngoscope"},{"key":"153_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/000348948909801108","volume":"98","author":"SD Rauch","year":"1989","unstructured":"Rauch SD, Merchant SN, Thedinger BA. Meniere\u2019s syndrome and endolymphatic hydrops: double-blind temporal bone study. Ann Otol Rhinol Laryngol. 1989;98:873\u201383.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MLG.0b013e31802c300c","volume":"117","author":"T Nakashima","year":"2007","unstructured":"Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere\u2019s disease. Laryngoscope. 2007;117:415\u201320.","journal-title":"Laryngoscope"},{"key":"153_CR12","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/MAO.0b013e318268d087","volume":"33","author":"R G\u00fcrkov","year":"2012","unstructured":"G\u00fcrkov R, Flatz W, Louza J, et al. Herniation of the membranous labyrinth into the horizontal semicircular canal is correlated with impaired caloric response in M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol. 2012;33:1375\u20139.","journal-title":"Otol Neurotol"},{"key":"153_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/VES-130498","volume":"23","author":"Y Agrawal","year":"2013","unstructured":"Agrawal Y, Ward BK, Minor LB. Vestibular dysfunction: prevalence, impact and need for targeted treatment. J Vestib Res. 2013;23:113\u20137.","journal-title":"J Vestib Res"},{"key":"153_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11940-015-0341-x","volume":"17","author":"JD Sharon","year":"2015","unstructured":"\u2022\u2022 Sharon JD, Trevino C, Schubert MC, Carey JP. Treatment of Meni\u00e8re\u2019s disease. Curr Treat Options Neurol. 2015;17:14. This article provides a complete review of the current therapeutic options in the management of Meni\u00e8re\u2019s disease. The treatment algorithm outlined in this paper is used by the authors of this review when caring for a patient with Meni\u00e8re\u2019s disease.","journal-title":"Curr Treat Options Neurol"},{"key":"153_CR15","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/lary.1977.87.11.1870","volume":"87","author":"N Torok","year":"1977","unstructured":"Torok N. Old and new in M\u00e9ni\u00e8re disease. Laryngoscope. 1977;87:1870\u20137.","journal-title":"Laryngoscope"},{"key":"153_CR16","doi-asserted-by":"publisher","first-page":"h6816","DOI":"10.1136\/bmj.h6816","volume":"352","author":"C Adrion","year":"2016","unstructured":"Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere\u2019s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:h6816.","journal-title":"BMJ"},{"key":"153_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/archotol.1981.00790410009002","volume":"107","author":"J Thomsen","year":"1981","unstructured":"Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere\u2019s disease: a double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol. 1981;107:271\u20137.","journal-title":"Arch Otolaryngol"},{"key":"153_CR18","first-page":"841","volume":"32","author":"WS Neville","year":"1939","unstructured":"Neville WS. Two cases of vertigo treated by intratympanic injection of alcohol. Proc R Soc Med. 1939;32:841.","journal-title":"Proc R Soc Med"},{"key":"153_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.otc.2004.04.001","volume":"37","author":"LR Lustig","year":"2004","unstructured":"Lustig LR. The history of intratympanic drug therapy in otology. Otolaryngol Clin N Am. 2004;37:1001\u201317.","journal-title":"Otolaryngol Clin N Am"},{"key":"153_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","volume":"372","author":"H Sajjadi","year":"2008","unstructured":"Sajjadi H, Paparella MM. Meniere\u2019s disease. Lancet. 2008;372:406\u201314.","journal-title":"Lancet"},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1001\/jama.2011.679","volume":"305","author":"SD Rauch","year":"2011","unstructured":"Rauch SD. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss. JAMA. 2011;305:2071.","journal-title":"JAMA"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.amjoto.2016.09.004","volume":"38","author":"MC Topf","year":"2017","unstructured":"Topf MC, Hsu DW, Adams DR, et al. Rate of tympanic membrane perforation after intratympanic steroid injection. Am J Otolaryngol. 2017;38:21\u20135.","journal-title":"Am J Otolaryngol"},{"key":"153_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/MAO.0b013e3182009d29","volume":"32","author":"F Piu","year":"2011","unstructured":"Piu F, Wang X, Fernandez R, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol. 2011;32:171\u20139.","journal-title":"Otol Neurotol"},{"key":"153_CR24","doi-asserted-by":"crossref","unstructured":"Rybak LP. Vestibular and auditory ototoxicity. In: Cummings otolaryngology\u2014head and neck surgery. 2010. pp 2169\u20132178.","DOI":"10.1016\/B978-0-323-05283-2.00155-5"},{"key":"153_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/019459987908700625","volume":"87","author":"BM Smith","year":"1979","unstructured":"Smith BM, Myers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg. 1979;87:888\u201391.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.heares.2016.10.003","volume":"342","author":"AN Salt","year":"2016","unstructured":"Salt AN, Hartsock JJ, Gill RM, et al. Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig. Hear Res. 2016;342:101\u201311.","journal-title":"Hear Res"},{"key":"153_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/000164801300366552","volume":"121","author":"MV Goycoolea","year":"2001","unstructured":"Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 2001;121:437\u201347.","journal-title":"Acta Otolaryngol"},{"key":"153_CR28","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1097\/00005537-200209000-00015","volume":"112","author":"Z Becvarovski","year":"2002","unstructured":"Becvarovski Z, Bojrab DI, Michaelides EM, et al. Round window gentamicin absorption: an in vivo human model. Laryngoscope. 2002;112:1610\u20133.","journal-title":"Laryngoscope"},{"key":"153_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0378-5955(01)00223-4","volume":"154","author":"AN Salt","year":"2001","unstructured":"Salt AN, Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res. 2001;154:88\u201397.","journal-title":"Hear Res"},{"key":"153_CR30","first-page":"586","volume":"18","author":"H Silverstein","year":"1997","unstructured":"Silverstein H, Rowan PT, Olds MJ, Rosenberg SI. Inner ear perfusion and the role of round window patency. Am J Otol. 1997;18:586\u20139.","journal-title":"Am J Otol"},{"key":"153_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MAO.0b013e31819bda66","volume":"30","author":"M Yoshioka","year":"2009","unstructured":"Yoshioka M, Naganawa S, Sone M, et al. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol. 2009;30:645\u20138.","journal-title":"Otol Neurotol"},{"key":"153_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/000348940010900105","volume":"109","author":"KS Alzamil","year":"2000","unstructured":"Alzamil KS, Linthicum FH Jr. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol. 2000;109:30\u20132.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"153_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.otc.2004.06.002","volume":"37","author":"J Carey","year":"2004","unstructured":"Carey J. Intratympanic gentamicin for the treatment of M\u00e9ni\u00e8re\u2019s disease and other forms of peripheral vertigo. Otolaryngol Clin N Am. 2004;37:1075\u201390.","journal-title":"Otolaryngol Clin N Am"},{"key":"153_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/infdis\/119.4-5.410","volume":"119","author":"J Wersall","year":"1969","unstructured":"Wersall J, Lundquist P-G, Bjorkroth B. Ototoxicity of gentamicin. J Infect Dis. 1969;119:410\u20136.","journal-title":"J Infect Dis"},{"key":"153_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/00016486909125441","volume":"67","author":"HH Lindeman","year":"1969","unstructured":"Lindeman HH. Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol. 1969;67:177\u201389.","journal-title":"Acta Otolaryngol"},{"key":"153_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0378-5955(90)90031-J","volume":"50","author":"JCMJ de Groot","year":"1990","unstructured":"de Groot JCMJ, Meeuwsen F, Ruizendaal WE, Veldman JE. Ultrastructural localization of gentamicin in the cochlea. Hear Res. 1990;50:35\u201342.","journal-title":"Hear Res"},{"key":"153_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/00034894001090S504","volume":"181","author":"K Tsuji","year":"2000","unstructured":"Tsuji K, Vel\u00e1zquez-Villase\u00f1or L, Rauch SD, et al. Temporal bone studies of the human peripheral vestibular system. Aminoglycoside ototoxicity. Ann Otol Rhinol Laryngol Suppl. 2000;181:20\u20135.","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"153_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10162-007-0093-8","volume":"8","author":"S Lyford-Pike","year":"2007","unstructured":"Lyford-Pike S, Vogelheim C, Chu E, et al. Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. J Assoc Res Otolaryngol. 2007;8:497\u2013508.","journal-title":"J Assoc Res Otolaryngol"},{"key":"153_CR39","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/MLG.0b013e31817c1303","volume":"118","author":"WY Bae","year":"2008","unstructured":"Bae WY, Kim LS, Hur DY, et al. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas\u2013Fas ligand signaling pathway. Laryngoscope. 2008;118:1659\u201368.","journal-title":"Laryngoscope"},{"key":"153_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10162-015-0515-y","volume":"16","author":"DQ Sun","year":"2015","unstructured":"Sun DQ, Lehar M, Dai C, et al. Histopathologic changes of the inner ear in rhesus monkeys after intratympanic gentamicin injection and vestibular prosthesis electrode array implantation. J Assoc Res Otolaryngol. 2015;16:373\u201387.","journal-title":"J Assoc Res Otolaryngol"},{"key":"153_CR41","first-page":"293","volume":"52","author":"EP Fowler Jr","year":"1948","unstructured":"Fowler EP Jr. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol. 1948;52:293\u2013301.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"153_CR42","doi-asserted-by":"crossref","unstructured":"Schuknecht HF. Ablation therapy for the relief of M\u00e9ni\u00e8re\u2019s disease. Trans Am Laryngol Rhinol Otol Soc. 1956; 589\u2013600.","DOI":"10.1288\/00005537-195607000-00005"},{"key":"153_CR43","first-page":"1","volume":"132","author":"HF Schuknecht","year":"1957","unstructured":"Schuknecht HF. Ablation therapy in the management of Meni\u00e8re\u2019s disease. Acta Otolaryngol Suppl. 1957;132:1\u201342.","journal-title":"Acta Otolaryngol Suppl"},{"key":"153_CR44","first-page":"1155","volume":"74","author":"JC Webster","year":"1970","unstructured":"Webster JC, McGee TM, Carroll R, et al. Ototoxicity of gentamicin. Histopathologic and functional results in the cat. Trans Am Acad Ophthalmol Otolaryngol. 1970;74:1155\u201365.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"153_CR45","doi-asserted-by":"crossref","unstructured":"Schatz A, Bugie E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria, 1944. Clin Orthop Relat Res. 2005; 3\u20136.","DOI":"10.1097\/01.blo.0000175887.98112.fe"},{"key":"153_CR46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/BF02121452","volume":"155","author":"C-A Hamberger","year":"1949","unstructured":"Hamberger C-A, Hyd\u00e9n H, Koch H. Streptomycin bei der M\u00e9ni\u00e8reschen Krankheit. Archiv f\u00fcr Ohren- Nasen- und Kehlkopfheilkunde. 1949;155:667\u201382.","journal-title":"Archiv f\u00fcr Ohren- Nasen- und Kehlkopfheilkunde"},{"key":"153_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/00034894840930S408","volume":"93","author":"H Silverstein","year":"1984","unstructured":"Silverstein H. Streptomycin treatment for Meniere\u2019s disease. Ann Otol Rhinol Laryngol. 1984;93:44\u20138.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"153_CR48","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1055\/s-2007-997832","volume":"74","author":"G Lange","year":"1995","unstructured":"Lange G. 27 years experiences with transtympanic aminoglycoside treatment of Meni\u00e8re\u2019s disease. Laryngorhinootologie. 1995;74:720\u20133.","journal-title":"Laryngorhinootologie"},{"key":"153_CR49","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/MAO.0b013e31817ef4e3","volume":"29","author":"J Jung","year":"2008","unstructured":"Jung J, Chun J, Kim N, et al. Evaluation of quality of life after intratympanic streptomycin injection in patients with M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol. 2008;29:816\u201323.","journal-title":"Otol Neurotol"},{"key":"153_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00129492-200405000-00023","volume":"25","author":"BM Kato","year":"2004","unstructured":"Kato BM, Maya Kato B, LaRouere MJ, et al. Evaluating quality of life after endolymphatic sac surgery: the M\u00e9ni\u00e8re\u2019s Disease Outcomes Questionnaire. Otol Neurotol. 2004;25:339\u201344.","journal-title":"Otol Neurotol"},{"key":"153_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/000348949910800403","volume":"108","author":"MP Murphy","year":"1999","unstructured":"Murphy MP, Gates GA. Measuring the effects of Meniere\u2019s disease: results of the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol Rhinol Laryngol. 1999;108:331\u20137.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"153_CR52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0030-6665(02)00025-7","volume":"35","author":"WE Berryhill","year":"2002","unstructured":"Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere\u2019s disease. Otolaryngol Clin N Am. 2002;35:675\u201382.","journal-title":"Otolaryngol Clin N Am"},{"key":"153_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1749-4486.2012.02531.x","volume":"37","author":"SH Kim","year":"2012","unstructured":"Kim SH, Choi HS, Koh SH, et al. The revaluation of a single low dose of streptomycin powder in chemical labyrinthectomy for M\u00e9ni\u00e8re\u2019s disease: our experience in ninety-eight patients. Clin Otolaryngol. 2012;37:491\u20136.","journal-title":"Clin Otolaryngol"},{"key":"153_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","volume":"113","author":"IC Wu","year":"2003","unstructured":"Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease. Laryngoscope. 2003;113:815\u201320.","journal-title":"Laryngoscope"},{"key":"153_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF00455886","volume":"221","author":"C Beck","year":"1978","unstructured":"Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meni\u00e8re. Arch Otorhinolaryngol. 1978;221:149\u201352.","journal-title":"Arch Otorhinolaryngol"},{"key":"153_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1055\/s-2007-1008508","volume":"61","author":"D Katzke","year":"1982","unstructured":"Katzke D. Treatment of M\u00e9ni\u00e8re\u2019s disease with intratympanically applied gentamycin sulphate. Laryngol Rhinol Otol. 1982;61:4\u20138.","journal-title":"Laryngol Rhinol Otol"},{"key":"153_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1055\/s-2007-998424","volume":"68","author":"RE Blessing","year":"1989","unstructured":"Blessing RE, Schlenter WW. Long-term results of gentamycin therapy of Meni\u00e8re\u2019s disease. Laryngorhinootologie. 1989;68:657\u201360.","journal-title":"Laryngorhinootologie"},{"key":"153_CR58","first-page":"383","volume":"9","author":"C M\u00f6ller","year":"1988","unstructured":"M\u00f6ller C, Odkvist LM, Thell J, et al. Vestibular and audiologic functions in gentamicin-treated Meni\u00e8re\u2019s disease. Am J Otol. 1988;9:383\u201391.","journal-title":"Am J Otol"},{"key":"153_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/00016488809138889","volume":"105","author":"LM \u00d6dkvist","year":"1988","unstructured":"\u00d6dkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol. 1988;105:83\u20136.","journal-title":"Acta Otolaryngol"},{"key":"153_CR60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2273.1990.tb00796.x","volume":"15","author":"K Laitakari","year":"1990","unstructured":"Laitakari K. Intratympanic gentamycin in severe Meni\u00e8re\u2019s disease. Clin Otolaryngol. 1990;15:545\u20138.","journal-title":"Clin Otolaryngol"},{"key":"153_CR61","first-page":"18","volume":"13","author":"JM Nedzelski","year":"1992","unstructured":"Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meni\u00e8re\u2019s disease. Am J Otol. 1992;13:18\u201322.","journal-title":"Am J Otol"},{"key":"153_CR62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0196-0709(93)90076-J","volume":"14","author":"JM Nedzelski","year":"1993","unstructured":"Nedzelski JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Meni\u00e8re\u2019s disease: update of an ongoing study. Am J Otol. 1993;14:278\u201382.","journal-title":"Am J Otol"},{"key":"153_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2310\/7070.2002.19065","volume":"31","author":"DM Kaplan","year":"2002","unstructured":"Kaplan DM, Nedzelski JM, Al-Abidi A, et al. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere\u2019s disease. J Otolaryngol. 2002;31:106\u201311.","journal-title":"J Otolaryngol"},{"key":"153_CR64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/00016489109128051","volume":"111","author":"M Magnusson","year":"1991","unstructured":"Magnusson M, Padoan S, Karlberg M, Johansson R. Delayed onset of ototoxic effects of gentamicin in patients with Meniere\u2019s disease. Acta Otolaryngol. 1991;111:120\u20132.","journal-title":"Acta Otolaryngol"},{"key":"153_CR65","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/00016489109131484","volume":"481","author":"M Magnusson","year":"1991","unstructured":"Magnusson M, Padoan S, Karlberg M, Johansson R. Delayed onset of ototoxic effects of gentamicin in treatment of Meni\u00e8re\u2019s disease. Acta Otolaryngol Suppl. 1991;481:610\u20132.","journal-title":"Acta Otolaryngol Suppl"},{"key":"153_CR66","first-page":"340","volume":"24","author":"AA Toth","year":"1995","unstructured":"Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meni\u00e8re\u2019s disease: preliminary comparison of two regimens. J Otolaryngol. 1995;24:340\u20134.","journal-title":"J Otolaryngol"},{"key":"153_CR67","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2310\/7070.2003.11249","volume":"32","author":"J Atlas","year":"2003","unstructured":"Atlas J, Parnes LS. Intratympanic gentamicin for intractable Meniere\u2019s disease: 5-year follow-up. J Otolaryngol. 2003;32:288.","journal-title":"J Otolaryngol"},{"key":"153_CR68","doi-asserted-by":"crossref","unstructured":"Pullens B, van Benthem PP (2010) Intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev","DOI":"10.1002\/14651858.CD008234"},{"key":"153_CR69","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/coa.12449","volume":"40","author":"MI Syed","year":"2015","unstructured":"Syed MI, Ilan O, Nassar J, Rutka JA. Intratympanic therapy in Meniere\u2019s syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol. 2015;40:682\u201390.","journal-title":"Clin Otolaryngol"},{"key":"153_CR70","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/00016480410016621","volume":"124","author":"R Stokroos","year":"2004","unstructured":"Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active M\u00e9ni\u00e8re\u2019s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol. 2004;124:172\u20135.","journal-title":"Acta Otolaryngol"},{"key":"153_CR71","first-page":"CD008234","volume":"3","author":"B Pullens","year":"2011","unstructured":"Pullens B, van Benthem PP. Intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2011;3:CD008234.","journal-title":"Cochrane Database Syst Rev"},{"key":"153_CR72","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/00016480600951475","volume":"127","author":"L De Beer","year":"2007","unstructured":"De Beer L, Stokroos R, Kingma H. Intratympanic gentamicin therapy for intractable M\u00e9ni\u00e8re\u2019s disease. Acta Otolaryngol. 2007;127:605\u201312.","journal-title":"Acta Otolaryngol"},{"key":"153_CR73","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/00016480701762458","volume":"128","author":"RJ Postema","year":"2008","unstructured":"Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Meni\u00e8re\u2019s disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128:876\u201380.","journal-title":"Acta Otolaryngol"},{"key":"153_CR74","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2310\/7070.2003.13863","volume":"32","author":"C Diamond","year":"2003","unstructured":"Diamond C, Hornig JD, Liu R, O\u2019Connell DA. Systematic review of intratympanic gentamicin in Meniere\u2019s disease. J Otolaryngol. 2003;32:351.","journal-title":"J Otolaryngol"},{"key":"153_CR75","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","volume":"25","author":"SH Chia","year":"2004","unstructured":"Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for M\u00e9ni\u00e8re\u2019s disease: a meta-analysis. Otol Neurotol. 2004;25:544\u201352.","journal-title":"Otol Neurotol"},{"key":"153_CR76","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/01.mlg.0000149439.43478.24","volume":"114","author":"R Cohen-Kerem","year":"2004","unstructured":"Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Meni\u00e8re\u2019s disease: a meta-analysis. Laryngoscope. 2004;114:2085\u201391.","journal-title":"Laryngoscope"},{"key":"153_CR77","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/MAO.0b013e318259b3b1","volume":"33","author":"L-K Huon","year":"2012","unstructured":"Huon L-K, Fang T-Y, Wang P-C. Outcomes of intratympanic gentamicin injection to treat M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol. 2012;33:706\u201314.","journal-title":"Otol Neurotol"},{"key":"153_CR78","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00405-016-4294-9","volume":"274","author":"PV Vlastarakos","year":"2017","unstructured":"\u2022 Vlastarakos PV, Iacovou E, Nikolopoulos TP. Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere\u2019s disease? A critical analysis of published interventional studies. Eur Arch Otorhinolaryngol. 2017;274:1309\u201315. This systematic review article examines the evidence for sustained-release intratympanic gentamicin in Meni\u00e8re\u2019s disease. This article highlights the continued risk of hearing loss with the use of gentamicin noting that sustained-release formulations have an unacceptably high risk of complete or partial hearing loss.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"153_CR79","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.autrev.2012.01.004","volume":"11","author":"A Greco","year":"2012","unstructured":"Greco A, Gallo A, Fusconi M, et al. Meniere\u2019s disease might be an autoimmune condition? Autoimmun Rev. 2012;11:731\u20138.","journal-title":"Autoimmun Rev"},{"key":"153_CR80","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3109\/00016489.2013.820344","volume":"133","author":"E Martin-Sanz","year":"2013","unstructured":"Martin-Sanz E, Luzardo CZ, Riesco LR, et al. The use of electrocochleography to monitor the response of M\u00e9ni\u00e8re\u2019s disease patients to intratympanic steroids. Acta Otolaryngol. 2013;133:1158\u201364.","journal-title":"Acta Otolaryngol"},{"key":"153_CR81","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/lary.25057","volume":"125","author":"E Martin-Sanz","year":"2015","unstructured":"Martin-Sanz E, Esteban-Sanchez J, Rodriga\u00f1ez-Riesco L, Sanz-Fern\u00e1ndez R. Transitory effect on endolymphatic hydrops of the intratympanic steroids for M\u00e9ni\u00e8re\u2019s disease. Laryngoscope. 2015;125:1183\u20138.","journal-title":"Laryngoscope"},{"key":"153_CR82","doi-asserted-by":"publisher","first-page":"F1127","DOI":"10.1152\/ajprenal.00387.2003","volume":"286","author":"SR Pondugula","year":"2004","unstructured":"Pondugula SR, Sanneman JD, Wangemann P, et al. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. Am J Physiol Renal Physiol. 2004;286:F1127\u201335.","journal-title":"Am J Physiol Renal Physiol"},{"key":"153_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.heares.2005.10.006","volume":"212","author":"DR Trune","year":"2006","unstructured":"Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006;212:22\u201332.","journal-title":"Hear Res"},{"key":"153_CR84","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/00016489109131486","volume":"481","author":"A Itoh","year":"1991","unstructured":"Itoh A, Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl. 1991;481:617\u201323.","journal-title":"Acta Otolaryngol Suppl"},{"key":"153_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","volume":"109","author":"LS Parnes","year":"1999","unstructured":"Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1\u201317.","journal-title":"Laryngoscope"},{"key":"153_CR86","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","volume":"28","author":"PA Bird","year":"2007","unstructured":"Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28:1124\u201330.","journal-title":"Otol Neurotol"},{"key":"153_CR87","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","volume":"388","author":"M Patel","year":"2016","unstructured":"\u2022\u2022 Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re\u2019s disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016;388:2753\u201362. This is a well-conducted randomized, double-blind, comparative effectiveness trial which elucidates the efficacy of vertigo control in patients with unilateral M\u00e9ni\u00e8re\u2019s disease using methylprednisolone or gentamicin.","journal-title":"Lancet"},{"key":"153_CR88","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/014556130408300611","volume":"83","author":"KM Dodson","year":"2004","unstructured":"Dodson KM, Woodson E, Sismanis A. Intratympanic steroid perfusion for the treatment of M\u00e9ni\u00e8re\u2019s disease: a retrospective study. Ear Nose Throat J. 2004;83:394\u20138.","journal-title":"Ear Nose Throat J"},{"key":"153_CR89","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1017\/S0022215115000171","volume":"129","author":"W She","year":"2015","unstructured":"She W, Lv L, Du X, et al. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable M\u00e9ni\u00e8re\u2019s disease. J Laryngol Otol. 2015;129:232\u20137.","journal-title":"J Laryngol Otol"},{"key":"153_CR90","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0194599812472882","volume":"148","author":"N Gabra","year":"2013","unstructured":"Gabra N, Saliba I. The effect of intratympanic methylprednisolone and gentamicin injection on M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Head Neck Surg. 2013;148:642\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR91","first-page":"196","volume":"19","author":"H Silverstein","year":"1998","unstructured":"Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere\u2019s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196\u2013201.","journal-title":"Am J Otol"},{"issue":"2","key":"153_CR92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","volume":"133","author":"MA Gardu\u00f1o-Anaya","year":"2005","unstructured":"Gardu\u00f1o-Anaya MA, De Toledo HC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere\u2019s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Head Neck Surg. 2005;133(2):285\u201394.","journal-title":"Head Neck Surg"},{"key":"153_CR93","first-page":"CD008514","volume":"7","author":"JS Phillips","year":"2011","unstructured":"Phillips JS, Westerberg B. Intratympanic steroids for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2011;7:CD008514.","journal-title":"Cochrane Database Syst Rev"},{"key":"153_CR94","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00405-015-3689-3","volume":"273","author":"P Lavigne","year":"2016","unstructured":"Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol. 2016;273:2271\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"153_CR95","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0194599811429432","volume":"146","author":"AP Casani","year":"2012","unstructured":"Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral m\u00e9ni\u00e8re disease gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146:430\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1067\/mhn.2001.119485","volume":"125","author":"L Sennaroglu","year":"2001","unstructured":"Sennaroglu L, Sennaroglu G, Gursel B, Dini FM. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere\u2019s disease. Otolaryngol Head Neck Surg. 2001;125:537\u201343.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02907620","volume":"57","author":"G Paragache","year":"2005","unstructured":"Paragache G, Panda NK, Ragunathan M, Sridhara. Intratympanic dexamethasone application in Meniere\u2019s disease\u2014is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg. 2005;57:21\u20133.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"153_CR98","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.amjoto.2014.10.032","volume":"36","author":"S Albu","year":"2015","unstructured":"Albu S, Chirtes F, Trombitas V, et al. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease. Am J Otolaryngol. 2015;36:205\u20139.","journal-title":"Am J Otolaryngol"},{"key":"153_CR99","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/MAO.0b013e31828d655f","volume":"34","author":"E Martin Sanz","year":"2013","unstructured":"Martin Sanz E, Zschaeck C, Christiane ZL, et al. Control of vertigo after intratympanic corticoid therapy for unilateral M\u00e9ni\u00e8re\u2019s disease: a comparison of weekly versus daily fixed protocols. Otol Neurotol. 2013;34:1429\u201333.","journal-title":"Otol Neurotol"},{"key":"153_CR100","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/MAO.0b013e318263d35d","volume":"33","author":"PR Lambert","year":"2012","unstructured":"Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol. 2012;33:1257\u201365.","journal-title":"Otol Neurotol"},{"key":"153_CR101","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1097\/MAO.0000000000001227","volume":"37","author":"PR Lambert","year":"2016","unstructured":"\u2022 Lambert PR, Carey J, Mikulec AA, et al. Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of M\u00e9ni\u00e8re\u2019s disease: randomized phase 2b safety and efficacy trial. Otol Neurotol. 2016;37:1669\u201376. This is a randomized, placebo-controlled trial which demonstrated the safety and efficacy of a novel sustained delivery system for intratympanic dexamethasone for non-ablative management of M\u00e9ni\u00e8re\u2019s disease.","journal-title":"Otol Neurotol"},{"key":"153_CR102","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000111044","volume":"70","author":"J-P Guyot","year":"2008","unstructured":"Guyot J-P, Maire R, Delaspre O. Intratympanic application of an antiviral agent for the treatment of M\u00e9ni\u00e8re\u2019s disease. ORL J Otorhinolaryngol Relat Spec. 2008;70:21\u20136. discussion 26\u20137","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"153_CR103","first-page":"157","volume":"7","author":"J Verdonck","year":"2011","unstructured":"Verdonck J, Desloovere C. Intratympanic lidocaine instillation for Meni\u00e8re\u2019s disease. B-ENT. 2011;7:157\u201364.","journal-title":"B-ENT"},{"key":"153_CR104","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.otohns.2005.05.043","volume":"133","author":"H Rask-Andersen","year":"2005","unstructured":"Rask-Andersen H, Friberg U, Johansson M, Stjernschantz J. Effects of intratympanic injection of latanoprost in Meniere\u2019s disease: a randomized, placebo-controlled, double-blind, pilot study. Otolaryngol Head Neck Surg. 2005;133:441\u20133.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"153_CR105","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.carres.2013.03.019","volume":"373","author":"FR Pinsetta","year":"2013","unstructured":"Pinsetta FR, Kawano DF, de Carvalho MR, et al. Synthesis of neamine-based pseudodisaccharides as potential vestibulotoxic agents to treat vertigo in M\u00e9ni\u00e8re\u2019s disease. Carbohydr Res. 2013;373:97\u2013102.","journal-title":"Carbohydr Res"},{"key":"153_CR106","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s101620010053","volume":"3","author":"JP Carey","year":"2002","unstructured":"Carey JP, Minor LB, Peng GCY, et al. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease. JARO - J Assoc Res Otolaryngol. 2002;3:430\u201343.","journal-title":"JARO - J Assoc Res Otolaryngol"},{"key":"153_CR107","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1749-6632.2002.tb02888.x","volume":"956","author":"JP Carey","year":"2002","unstructured":"Carey JP, Hirvonen T, Peng GCY, et al. Changes in the angular vestibulo-ocular reflex after a single dose of intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease. Ann N Y Acad Sci. 2002;956:581\u20134.","journal-title":"Ann N Y Acad Sci"},{"key":"153_CR108","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/019459988910000102","volume":"100","author":"H Silverstein","year":"1989","unstructured":"Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere\u2019s disease. Otolaryngol Head Neck Surg. 1989;100:6\u201316.","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Current Otorhinolaryngology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40136-017-0153-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40136-017-0153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40136-017-0153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:29:56Z","timestamp":1658968196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40136-017-0153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s40136-017-0153-5","relation":{},"ISSN":["2167-583X"],"issn-type":[{"value":"2167-583X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"assertion":[{"value":"3 May 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Desi P Schoo, Dr. Grace X Tan, Matthew R Ehrenburg, Dr. Seth E Pross, and Dr. Bryan K Ward declare that they have no conflicts of interest. Dr. John P Carey declares that he is a site investigator for a clinical trial of OTO-104 in Meni\u00e8re\u2019s disease.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}